pre-IPO PHARMA

COMPANY OVERVIEW

Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    https://www.ascidian-tx.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS

    apple-tree-partners


    PRESS RELEASES


    May 9, 2023

    Ascidian Therapeutics to Present New Data From Its Lead Program Targeting ABCA4 Retinopathies at the ASGCT 2023 Annual Meeting


    Apr 18, 2023

    Ascidian Therapeutics to Present Data From Its Lead Program Targeting ABCA4 Retinopathies at the Retinal Cell and Gene Therapy Innovation Summit and ARVO 2023 Annual Meeting


    Apr 11, 2023

    Ascidian Therapeutics Announces Three Key Development Team Appointments as It Advances Its Lead Program Toward the Clinic


    Mar 20, 2023

    Ascidian Therapeutics Appoints Jay A. Barth, M.D., as Chief Medical Officer


    Jan 4, 2023

    Ascidian Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference


    For More Press Releases


    Google Analytics Alternative